Next Article in Journal
Identification of Two Novel Anti-Fibrotic Benzopyran Compounds Produced by Engineered Strains Derived from Streptomyces xiamenensis M1-94P that Originated from Deep-Sea Sediments
Next Article in Special Issue
Trypanocidal Activity of Marine Natural Products
Previous Article in Journal
Biosynthesis of Polyunsaturated Fatty Acids in Marine Invertebrates: Recent Advances in Molecular Mechanisms
Previous Article in Special Issue
Synthesis of Marine α-Methoxylated Fatty Acid Analogs that Effectively Inhibit the Topoisomerase IB from Leishmania donovani with a Mechanism Different from that of Camptothecin
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2013, 11(10), 4019-4034; doi:10.3390/md11104019

Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds

1
Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London, London WC1N 1AX, UK
2
Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel CH-4002, Switzerland
3
University of Basel, Petersplatz 1, Basel CH-4003, Switzerland
4
Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon 1649-028, Portugal
5
School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2DT, UK
6
School of Chemistry, National University of Ireland, Galway, Ireland
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 13 August 2013 / Revised: 8 October 2013 / Accepted: 11 October 2013 / Published: 22 October 2013
(This article belongs to the Special Issue Antiprotozoal Marine Natural Products)
View Full-Text   |   Download PDF [749 KB, uploaded 24 February 2015]   |  

Abstract

Terrestrial plants have proven to be a prolific producer of clinically effective antimalarial drugs, but the antimalarial potential of seaweeds has been little explored. The main aim of this study was to assess the in vitro chemotherapeutical and prophylactic potential of the extracts of twenty-three seaweeds collected from the south coast of England against blood stage (BS) and liver stage (LS) Plasmodium parasites. The majority (14) of the extracts were active against BS of P. falciparum, with brown seaweeds Cystoseira tamariscifolia, C. baccata and the green seaweed Ulva lactuca being the most active (IC50s around 3 μg/mL). The extracts generally had high selectivity indices (>10). Eight seaweed extracts inhibited the growth of LS parasites of P. berghei without any obvious effect on the viability of the human hepatoma (Huh7) cells, and the highest potential was exerted by U. lactuca and red seaweeds Ceramium virgatum and Halopitys incurvus (IC50 values 14.9 to 28.8 μg/mL). The LS-active extracts inhibited one or more key enzymes of the malarial type-II fatty acid biosynthesis (FAS-II) pathway, a drug target specific for LS. Except for the red seaweed Halopitys incurvus, all LS-active extracts showed dual activity versus both malarial intracellular stage parasites. This is the first report of LS antiplasmodial activity and dual stage inhibitory potential of seaweeds.
Keywords: seaweed; marine alga; malaria; Plasmodium; malaria prophylaxis; fatty acid biosynthesis; liver stage; blood stage seaweed; marine alga; malaria; Plasmodium; malaria prophylaxis; fatty acid biosynthesis; liver stage; blood stage
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Spavieri, J.; Allmendinger, A.; Kaiser, M.; Itoe, M.A.; Blunden, G.; Mota, M.M.; Tasdemir, D. Assessment of Dual Life Stage Antiplasmodial Activity of British Seaweeds. Mar. Drugs 2013, 11, 4019-4034.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top